Market

Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports

Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports
Read More

Related Posts

Brown Forman stock price target raised to $32 by Evercore ISI

Brown Forman stock price target raised to $32 by Everco...

Trump administration says Europe risks 'civilisational erasure', drawing outcry

Trump administration says Europe risks 'civilisational ...

Form 144 eToro Group Ltd For: 5 December

Form 144 eToro Group Ltd For: 5 December

‘Soon, all commodity charts will look like gold.’ BofA’s Hartnett goes bullish on commodities.

‘Soon, all commodity charts will look like gold.’ BofA’...

New York Times sues Perplexity AI for ’illegal’ copying of content

New York Times sues Perplexity AI for ’illegal’ copying...

German industrial orders rise more than expected in October

German industrial orders rise more than expected in Oct...